Linda Brown
Internal Medicine · Wyomissing, PANPI 1689761074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Harmony Biosciences LLC at 24.7% of the total. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$1K
- AbbVie$966
- Jazz Pharmaceuticals Inc.$763
- Axsome Therapeutics, Inc.$215
- Lilly USA, LLC$190
- Teva Pharmaceuticals USA, Inc.$172
- plus $985 from 16 others
What the payments were for
- Food & beverage$4,22597%
- Education$1453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 72 | $1,080 |
| AbbVie | 50 | $966 |
| Jazz Pharmaceuticals Inc. | 33 | $763 |
| Axsome Therapeutics, Inc. | 11 | $215 |
| Lilly USA, LLC | 11 | $190 |
| Teva Pharmaceuticals USA, Inc. | 11 | $172 |
| Biohaven Pharmaceuticals, Inc. | 6 | $155 |
| AstraZeneca | 6 | $145 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $132 |
| Amneal Pharmaceuticals LLC | 7 | $111 |
| Neurocrine Biosciences, Inc. | 4 | $104 |
| Pfizer | 3 | $67 |
| Vifor Pharma, Inc. | 3 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Amgen | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Novartis | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $16 |
How this compares
$4,370 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RizatriptanRizatriptan Benzoate | 11 | $101 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Wyomissing
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.